TABLE 3 .
Distribution of the most frequent neisserial heparin-binding antigen peptides in the panel of 442 strains
| NHBA peptide IDa | Frequency (n = 442) | % of total | Predicted coverage (95% CI) by NHBA | Predicted coverage (95% CI) by all antigens |
|---|---|---|---|---|
| 5 | 127 | 29% | 87% (31%–100%) | 100% (98%–100%) |
| 20 | 43 | 9.7% | 98% (53%–100%) | 98% (63%–100%) |
| 2b | 42 | 9.5% | 100% (93%–100%) | 100% (100%–100%) |
| 10 | 29 | 6.6% | 97% (55%–100%) | 97% (55%–100%) |
| 29 | 26 | 5.9% | 92% (31%–100%) | 96% (42%–100%) |
| 3 | 26 | 5.9% | 100% (88%–100%) | 100% (96%–100%) |
| 21 | 25 | 5.7% | 84% (40%–92%) | 88% (40%–96%) |
| 1 | 18 | 4.1% | 100% (100%–100%) | 100% (100%–100%) |
| Other (n = 47) | 106 | 24% | 50% (21%–71%) | 69% (41%–84%) |
a
ID, identification number in PubMLST Neisseria sequence typing database.
b
Peptide included in the MenB-4C multicomponent vaccine.